February 28, 2005
U.S. Genomics Expands Early Access Program with the Addition of Four Leading Research Laboratories
February 14, 2005
U.S. Genomics Sponsors Award for Outstanding Investigator in the Field of Single Molecule Biology
November 16, 2004
Tim Germann joins U.S. Genomics as Vice President of Sales and Marketing
November 9, 2004
U.S. Genomics Places First Trilogy Instrument with Mount Sinai School of Medicine
October 25, 2004
U.S. Genomics Launches Direct™ miRNA Reagents for Trilogy™ Platform
September 28, 2004
U.S. Genomics Expands into Larger Facility with Cummings Properties
September 15, 2004
U.S. Genomics’ Trilogy™ Wins IBO Industrial Design Award
August 9, 2004
U.S. Genomics Presents Trilogy™ Instrument Platform for Single Molecule Analysis
May 10, 2004
U.S. Genomics Awarded $7.5 Million Bio-Defense Contract from U.S. Department of Homeland Security
April 14, 2004
U.S. Genomics Licenses Locked Nucleic Acid (LNA™) Chemistries from Exiqon
March 23, 2004
U.S. Genomics Announces Trilogy™ Platform for Direct Analysis of Single Molecules Without Amplification
February 11, 2004
Dr. J. Craig Venter to Chair U.S. Genomics Scientific Advisory Board
October 16, 2003
U.S. Genomics Names John J. Canepa as Vice President of Finance and Chief Financial Officer
September 29, 2003
U.S. Genomics Awarded $500K Phase II SBIR Grant from the National Science Foundation
May 7, 2003
U.S. Genomics secures $25 Million in Equity Financing
March 26, 2003
U.S. Genomics Names Stephen P. DeFalco, Former PerkinElmer Executive, as New Chief Executive Officer and Chairman
October 22, 2002
U.S. Genomics awarded patent for DNA analysis methods
September 04, 2002
U.S. Genomics Awarded $499,500 DARPA Contract to examine applicability of Genomic mapping technology
August 15, 2002
J. Craig Venter, Ph.D., joins the Board of Directors at U.S. Genomics
March 18, 2002
U.S. Genomics Awarded Pioneering Patent for Direct, Linear Analysis of DNA
February 20, 2002
U.S. Genomics to Collaborate with Dr. Pui-Yan Kwok, Leading Geneticist at Washington University, for Genetic Research, Technology Development
January 28, 2002
U.S. Genomics and The Wellcome Trust Sanger Institute to Collaborate on Genetic Discovery
November 15, 2001
U.S. Genomics Appoints David Hoey As Vice President of Business Development
October 31, 2001
U.S. Genomics Appoints Michael B. Olex As Senior Vice President of Operations and Manufacturing
July 18, 2001
U.S. Genomics Awarded Patent Using Fluorophores in Direct, Linear DNA Analysis
June 13, 2001
U.S. Genomics Receives First U.S. Patent for Molecular Motors
April 4, 2001
U.S. Genomics Announces $17 Million Private Financing to Advance Pioneering Technology for Direct, Linear Analysis of DNA